Andera Partners
Overview
Andera Partners is a private equity firm that specializes in investments across life sciences, growth and buyout capital, sponsorless transactions, and ecological transition . The firm offers various investment strategies to support companies, including Andera Life Sciences, Andera Infra, Andera Croissance, Andera Expansion, Andera MidCap, and Andera Acto . It seeks to assist companies and their management teams in achieving strong and sustainable growth through expertise in investment and business strategy .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rivermark Medical | May 2026 | Series D | Lead |
| Alveus Therapeutics | Feb 2026 | Series A Extension | Lead |
| Exciva GmbH | Jan 2026 | Series B | Co-investor |
| Alveus Therapeutics | Jan 2026 | Series A | Lead |
| Spiro Medical | Jan 2026 | Series A | Lead |
Key People
Loan Hoang-Sayag
Venture Partner
Raymond W. Cohen
Venture Partner
Alexander Cuniasse
Advising Partner Andera Co-Invest
Antoine Le Bourgeois
Partner
Arnaud Faure
Partner Andera Acto
Bruno Bonnin
Partner
Jan Van den Bossche
Partner
Laurent Tourtois
Partner
Léopold Brichard
Partner
Massimo Massari
Partner
Olivier Le Gall
Partner
Sophie Elkrief
Partner
Stéphane BERGEZ
Partner, Head Of Andera Acto
Guillaume Thomas
Director, Investor Relations
Elyes Chouaieb
Venture Capital - Life Sciences Investment Director
Mathieu Pieronne
Investment Director, Venture Capital Life Sciences
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
